|
This section
provides patients and their families with information on three
of the most important subjects confronted by a patient seeking
to take manage chronic hepatitis B or C.
While no one
drug can cure hepatitis, some are increasingly effective in treating
it. Interferon remains the most common treatment for hepatitis
B and C, especially when used in combination with other substances.
In addition to interferon-based therapies, additional drugs are
in research or clinical trial stages.
To date, vaccines exist for hepatitis A and B, but not for C.
Researchers, however, are working on both preventive and therapeutic
vaccines.
If you or
a family member has hepatitis, learn how your health insurance
policy works. Extent of coverage usually depends on the type of
plan you have. While group plans cannot deny you insurance, they
can limit medications covered and access to treatments and tests,
and limit the annual and lifetime amount they will pay for treatment.
Since state and federal laws regulate health insurance coverage,
you need to know what safeguards and regulations your state's
insurance laws provide you.
If you don't
have insurance, options for obtaining treatment and medicine are
available. You also may be eligible for government programs.
Clinical trials
are research studies used to determine the safety and effectiveness
of new drugs and treatments. The trials, sponsored by government
agencies, pharmaceutical companies, healthcare organizations,
and individual researchers, are open to participants only after
they've shown promising results in laboratory and animal studies.
Participating in a study can offer you the chance to try a new
treatment that may (or may not) be better than what is more widely
available. Clinical trials for hepatitis are ongoing, at universities,
hospitals and in doctors' offices.
|